Entry |
|
Name |
Elacridar hydrochloride (USAN) |
Formula |
C34H33N3O5. HCl
|
Exact mass |
599.2187
|
Mol weight |
600.10
|
Structure |

|
Efficacy |
Antineoplastic (adjunct), P-Glycoprotein inhibitor |
Target |
|
Pathway |
|
Brite |
Target-based classification of drugs [BR:br08310]
Transporters
ABC transporters
ABCB (MDR/TAP) subfamily
ABCB1 (CD243)
D03968 Elacridar hydrochloride (USAN)
|
Other DBs |
|
LinkDB |
|
KCF data |
ATOM 43
1 C8x C 27.7200 -12.3200
2 C8x C 27.7200 -13.7200
3 C8y C 28.9324 -14.4200
4 C8y C 30.1449 -13.7200
5 C8y C 30.1449 -12.3200
6 C8x C 28.9324 -11.6200
7 N4x N 31.3573 -14.4200
8 C8y C 32.5697 -13.7200
9 C8y C 32.5697 -12.3200
10 C8y C 31.3573 -11.6200
11 C8y C 33.7822 -14.4200
12 C8x C 34.9946 -13.7200
13 C8x C 34.9946 -12.3200
14 C8x C 33.7822 -11.6200
15 O5x O 31.3573 -10.2200
16 C5a C 28.9324 -15.8198
17 N1b N 27.7032 -16.5297
18 O5a O 30.1280 -16.5102
19 C8y C 26.4992 -15.8346
20 C8x C 26.4989 -14.4203
21 C8x C 25.2863 -13.7206
22 C8y C 24.0740 -14.4209
23 C8x C 24.0744 -15.8352
24 C8x C 25.2870 -16.5349
25 C1b C 22.8655 -13.7236
26 C1b C 21.6733 -14.4125
27 N1y N 20.4840 -13.7263
28 C1x C 20.4835 -12.3203
29 C1x C 19.2708 -11.6207
30 C8y C 18.0586 -12.3211
31 C8y C 18.0591 -13.7271
32 C1x C 19.2718 -14.4267
33 C8x C 16.8460 -11.6215
34 C8y C 15.6338 -12.3219
35 C8y C 15.6342 -13.7279
36 C8x C 16.8469 -14.4275
37 O2a O 14.4026 -11.6114
38 O2a O 14.4075 -14.4369
39 C1a C 13.1969 -13.7388
40 C1a C 13.1998 -12.3063
41 O2a O 33.7822 -15.8197
42 C1a C 35.0154 -16.5320
43 X Cl 31.2200 -19.1100
BOND 47
1 1 2 2
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 2
6 1 6 1
7 4 7 1
8 7 8 1
9 8 9 1
10 9 10 1
11 5 10 1
12 8 11 2
13 11 12 1
14 12 13 2
15 13 14 1
16 9 14 2
17 10 15 2
18 3 16 1
19 16 17 1
20 16 18 2
21 17 19 1
22 19 20 2
23 20 21 1
24 21 22 2
25 22 23 1
26 23 24 2
27 19 24 1
28 22 25 1
29 25 26 1
30 26 27 1
31 27 28 1
32 28 29 1
33 29 30 1
34 30 31 1
35 31 32 1
36 27 32 1
37 30 33 2
38 33 34 1
39 34 35 2
40 35 36 1
41 31 36 2
42 34 37 1
43 35 38 1
44 38 39 1
45 37 40 1
46 11 41 1
47 41 42 1
|